Today: 19 June 2026

Tesla stock (TSLA) rebounds to $445 as CES self-driving push keeps robotaxi story in play

Tesla stock (TSLA) rebounds to $445 as CES self-driving push keeps robotaxi story in play

Tesla shares rose 2.1% to $445.01 Friday, with 74 million shares traded. The stock moved between $430.40 and $448.78 as investors looked ahead to inflation data and Tesla’s upcoming results. Tesla faces pressure from the end of U.S. EV tax credits and competition from BYD, which surpassed it in annual EV sales. The S&P 500 closed at a record high after U.S. payrolls data came in below expectations.
10 January 2026
·
Broadcom stock jumps after Mizuho lifts target; CPI week sets up next test for AVGO

Broadcom stock jumps after Mizuho lifts target; CPI week sets up next test for AVGO

Broadcom shares jumped 3.7% to $344.97 Friday, lifting the PHLX Semiconductor Index to a record. Mizuho raised its price target on Broadcom to $480, citing “attractive valuations.” Cathie Wood’s ARK Invest bought 31,573 shares, while Broadcom’s legal chief sold 30,000 shares. The stock remains 17% below its 52-week high after a December warning on profit margins.
10 January 2026
···
Revolution Medicines stock jumps on Merck buyout buzz and an FDA breakthrough tag — what to watch Monday

Revolution Medicines stock jumps on Merck buyout buzz and an FDA breakthrough tag — what to watch Monday

Revolution Medicines shares surged 10.7% to $118.64 Friday after reports that Merck is in talks for a $28–32 billion takeover. The FDA granted Breakthrough Therapy status to its lung cancer drug zoldonrasib. Insider filings show the CFO and COO sold shares earlier in the week under pre-arranged plans. Revolution denied rumors of a separate AbbVie bid.
10 January 2026
·
Meta stock ends up after nuclear power deals as WhatsApp EU rules, China review loom

Meta stock ends up after nuclear power deals as WhatsApp EU rules, China review loom

Meta shares closed up 1.1% at $653.06 after announcing 20-year nuclear power deals with Vistra, Oklo, and TerraPower, aiming for up to 6.6 gigawatts by 2035. European and Chinese regulators launched new investigations into Meta this week. In Europe, WhatsApp Channels exceeded the EU’s regulatory threshold, triggering possible stricter rules. China will review Meta’s acquisition of AI startup Manus.
10 January 2026
···
Azul S.A. Sponsored ADR Pfd (AZULD) faces fresh dilution math after board tweaks debt-to-equity terms

Azul S.A. Sponsored ADR Pfd (AZULD) faces fresh dilution math after board tweaks debt-to-equity terms

Azul’s board approved new terms for converting 908,401 mandatory debentures into 1.36 trillion preferred shares as part of its U.S. Chapter 11 plan, meeting minutes showed Friday. The company’s Brazil share offering, tied to the plan, will not extend to ADR holders. Interest on the debentures will be extinguished at conversion. Annual and Q4 results are scheduled for Feb. 26.
10 January 2026
··
Microsoft stock has a new AI-commerce catalyst as Copilot Checkout rolls out with PayPal

Microsoft stock has a new AI-commerce catalyst as Copilot Checkout rolls out with PayPal

Microsoft shares rose 0.2% to $479.28 Friday after the company launched Copilot Checkout and new “agentic AI” tools for retailers. PayPal will handle payments for the new platform. The S&P 500 closed at a record high, up 0.6%. U.S. CPI data is due Jan. 13, with Microsoft’s Q2 earnings set for Jan. 28.
10 January 2026
·····
Nvidia stock: What traders watch Monday after China H200 payment terms tighten

Nvidia stock: What traders watch Monday after China H200 payment terms tighten

Nvidia shares slipped 0.1% to $184.86 Friday amid tighter H200 chip sales terms for China and new auto partnerships announced at CES. The company now requires full upfront payment from Chinese buyers, with no cancellations or refunds allowed, as regulators review chip import rules. TSMC, Nvidia’s main supplier, reported a 20.45% revenue jump and will issue guidance Jan. 15. Nvidia reports earnings Feb. 25.
10 January 2026
··
SoundHound AI stock jumps 7% as Wall Street resets targets after CES demos

SoundHound AI stock jumps 7% as Wall Street resets targets after CES demos

SoundHound AI shares closed up 6.7% at $11.75 Friday, with 39.3 million shares traded after CES product demos and news of a TomTom partnership. DA Davidson cut its price target to $14, while Oppenheimer and Cantor Fitzgerald maintained their ratings. The stock finished below key moving averages. Investors await Tuesday’s U.S. CPI data and SoundHound’s next earnings report, estimated for Feb. 26.
10 January 2026
··
SoFi stock slips as SEC filing details adviser pay for retiring general counsel; earnings next

SoFi stock slips as SEC filing details adviser pay for retiring general counsel; earnings next

SoFi shares fell 1.1% to $27.40 Friday after the company disclosed a new paid adviser role for former general counsel Stephen Simcock, who retired Dec. 31. Simcock will receive $83,333.33 per month and COBRA subsidies through the end of 2026. Investors await U.S. inflation data and SoFi’s Jan. 30 earnings report. About 43.8 million shares traded in the session.
10 January 2026
·
Denison Mines stock: Phoenix uranium project gets SaskPower grid power as permits loom

Denison Mines stock: Phoenix uranium project gets SaskPower grid power as permits loom

Denison Mines says SaskPower grid electricity is now connected at its planned Phoenix uranium mine in northern Saskatchewan. Denison’s U.S.-listed shares slipped 0.8% to $3.31 on Friday after touching $3.51. Construction at Phoenix still requires final permits and a board decision. Investors are watching uranium prices and the U.S. inflation report due Jan. 13.
10 January 2026
··
1 … 920 921 922 923 924 … 2,085

Stock Market Today

  • uniQure Shares Surge 78% on FDA Support for AMT-130 Accelerated Approval
    June 19, 2026, 3:49 PM EDT. uniQure's stock jumped 78.4% after the FDA indicated that three-year phase I/II data for AMT-130, a gene therapy for Huntington's disease, could support a biologics license application (BLA) for accelerated approval. The FDA requested alignment on a confirmatory study design, favoring a control group over sham surgery, with plans expected before a 2026 Q3 BLA filing. This update follows earlier regulatory setbacks when the FDA questioned the sufficiency of phase I/II data compared to external controls. AMT-130 uses gene-silencing microRNA to target the huntingtin gene. The therapy is evaluated in ongoing phase I/II trials assessing safety and efficacy. uniQure aims to begin confirmatory studies promptly under FDA collaboration.

Latest articles

WELL Health slides as TSX holds steady; Circle Medical, cash flow draw attention

WELL Health slides as TSX holds steady; Circle Medical, cash flow draw attention

19 June 2026
WELL Health plunged 3.7% to C$4.19 in Toronto as investors looked past director election results and focused on falling Q1 operating adjusted free cash flow, which dropped to C$1.6 million from C$11.8 million a year earlier due to clinic investments, higher cash taxes, Circle Medical deferrals, and increased interest payments.
MDA Space stock rises as Blue Canyon deal targets U.S. defense market

MDA Space stock rises as Blue Canyon deal targets U.S. defense market

19 June 2026
MDA Space’s Toronto shares jumped 4.4% to C$58.08 after it agreed to buy Blue Canyon Technologies from RTX’s Raytheon for US$620 million cash, a move aimed at expanding access to U.S. defense-space work and classified programs; the deal is expected to add to adjusted EBITDA and EPS in 2027 but faces regulatory approval and integration risks.
Fermi rally stalls with Nasdaq closed for Juneteenth as proxy fight simmers

Fermi rally stalls with Nasdaq closed for Juneteenth as proxy fight simmers

19 June 2026
Fermi surged 10% to $9.50 before the Juneteenth market closure, fueled by speculation of a potential OpenAI-related customer for its Project Matador campus, but no binding tenant deal has been announced, leaving the rally exposed to profit-taking if a concrete agreement or joint venture isn’t revealed when trading resumes.
Go toTop